486 related articles for article (PubMed ID: 3514684)
1. Use of Leu M1 and antiepithelial membrane antigen monoclonal antibodies for diagnosing Hodgkin's disease.
Jack AS; Cunningham D; Soukop M; Liddle CN; Lee FD
J Clin Pathol; 1986 Mar; 39(3):267-70. PubMed ID: 3514684
[TBL] [Abstract][Full Text] [Related]
2. Monoclonal antibodies in the diagnosis of Hodgkin's disease. The search for a rational panel.
Chittal SM; Caverivière P; Schwarting R; Gerdes J; Al Saati T; Rigal-Huguet F; Stein H; Delsol G
Am J Surg Pathol; 1988 Jan; 12(1):9-21. PubMed ID: 2827535
[TBL] [Abstract][Full Text] [Related]
3. Utility of combining antigranulocyte with antileukocyte antibodies in differentiating Hodgkin's disease from non-Hodgkin's lymphoma.
Medeiros LJ; Weiss LM; Warnke RA; Dorfman RF
Cancer; 1988 Dec; 62(12):2475-81. PubMed ID: 2973368
[TBL] [Abstract][Full Text] [Related]
4. The spectrum of Leu-M1 staining in lymphoid and hematopoietic proliferations.
Swerdlow SH; Wright SA
Am J Clin Pathol; 1986 Mar; 85(3):283-8. PubMed ID: 2428238
[TBL] [Abstract][Full Text] [Related]
5. Utility of Leu M1 monoclonal antibody in the differential diagnosis of Hodgkin's disease.
Hyder DM; Schnitzer B
Arch Pathol Lab Med; 1986 May; 110(5):416-9. PubMed ID: 3516118
[TBL] [Abstract][Full Text] [Related]
6. Leu M1 and S100 in Hodgkin's disease and non-Hodgkin's lymphomas.
Kornstein MJ; Bonner H; Gee B; Cohen R; Brooks JJ
Am J Clin Pathol; 1986 Apr; 85(4):433-7. PubMed ID: 3754087
[TBL] [Abstract][Full Text] [Related]
7. Monoclonal antibodies reactive in routinely processed tissue sections of malignant lymphoma, with emphasis on T-cell lymphomas.
Strickler JG; Weiss LM; Copenhaver CM; Bindl J; McDaid R; Buck D; Warnke R
Hum Pathol; 1987 Aug; 18(8):808-14. PubMed ID: 3301626
[TBL] [Abstract][Full Text] [Related]
8. Leu-M1--a marker for Reed-Sternberg cells in Hodgkin's disease. An immunoperoxidase study of paraffin-embedded tissues.
Pinkus GS; Thomas P; Said JW
Am J Pathol; 1985 May; 119(2):244-52. PubMed ID: 3887932
[TBL] [Abstract][Full Text] [Related]
9. Non-Hodgkin's lymphoma following Hodgkin's disease. A case report and immunohistochemical corroboration.
Shimizu K; Hara K; Kunii A
Am J Clin Pathol; 1986 Sep; 86(3):370-4. PubMed ID: 3529930
[TBL] [Abstract][Full Text] [Related]
10. Lymphocyte predominance Hodgkin's disease--an immunohistochemical study.
Nicholas DS; Harris S; Wright DH
Histopathology; 1990 Feb; 16(2):157-65. PubMed ID: 2323737
[TBL] [Abstract][Full Text] [Related]
11. Phenotypic analysis by flow cytometry of surface immunoglobulin light chains and B and T cell antigens in lymph nodes involved with non-Hodgkin's lymphoma.
Liendo C; Danieu L; Al-Katib A; Koziner B
Am J Med; 1985 Oct; 79(4):445-54. PubMed ID: 3931469
[TBL] [Abstract][Full Text] [Related]
12. Hodgkin's disease, lymphocyte predominance type, nodular--a distinct entity? Unique staining profile for L&H variants of Reed-Sternberg cells defined by monoclonal antibodies to leukocyte common antigen, granulocyte-specific antigen, and B-cell-specific antigen.
Pinkus GS; Said JW
Am J Pathol; 1985 Jan; 118(1):1-6. PubMed ID: 3155594
[TBL] [Abstract][Full Text] [Related]
13. Granulocyte and HLA-D region specific monoclonal antibodies in the diagnosis of Hodgkin's disease.
Norton AJ; Isaacson PG
J Clin Pathol; 1985 Nov; 38(11):1241-6. PubMed ID: 3864794
[TBL] [Abstract][Full Text] [Related]
14. An evaluation of the utility of anti-granulocyte and anti-leukocyte monoclonal antibodies in the diagnosis of Hodgkin's disease.
Dorfman RF; Gatter KC; Pulford KA; Mason DY
Am J Pathol; 1986 Jun; 123(3):508-19. PubMed ID: 3717303
[TBL] [Abstract][Full Text] [Related]
15. Histiocyte-rich B-cell lymphoma. A distinct clinicopathologic entity possibly related to lymphocyte predominant Hodgkin's disease, paragranuloma subtype.
Delabie J; Vandenberghe E; Kennes C; Verhoef G; Foschini MP; Stul M; Cassiman JJ; De Wolf-Peeters C
Am J Surg Pathol; 1992 Jan; 16(1):37-48. PubMed ID: 1728195
[TBL] [Abstract][Full Text] [Related]
16. Occurrence and patterns of muramidase containing cells in Hodgkin's disease, non-Hodgkin's lymphomas, and reactive hyperplasia.
Ree HJ; Song JY; Leone LA; Crowley JP; Fanger H
Hum Pathol; 1981 Jan; 12(1):49-59. PubMed ID: 6162773
[TBL] [Abstract][Full Text] [Related]
17. Use of monoclonal antibodies for the typing of malignant lymphomas in routinely processed biopsy samples.
Lauritzen AF; Ralfkiaer E
APMIS; 1991 Jul; 99(7):631-9. PubMed ID: 2069805
[TBL] [Abstract][Full Text] [Related]
18. Dendritic reticulum cell immunoreactivity for low-affinity nerve growth factor receptor in malignant lymphomas.
Dorfman DM; Shahsafaei A
Mod Pathol; 1996 Oct; 9(10):959-65. PubMed ID: 8902831
[TBL] [Abstract][Full Text] [Related]
19. Leu M-1 antigen: comparative expression in Hodgkin's disease and T cell lymphoma.
Strauchen JA; Breakstone B
Hematol Oncol; 1987; 5(2):107-14. PubMed ID: 2885252
[TBL] [Abstract][Full Text] [Related]
20. T-lymphocyte subpopulations in B-cell-derived non-Hodgkin's lymphomas and Hodgkin's disease.
Knowles DM; Halper JP; Jakobiec FA
Cancer; 1984 Aug; 54(4):644-51. PubMed ID: 6234982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
